Wohlford GF, Van Tassell BW, Billingsley HE, Kadariya D, et al. A Phase IB, Randomized, Double-Blinded, Dose Escalation, Single Center,
Repeat-Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor
Dapansutrile in Subjects with NYHA II-III Systolic Heart Failure. J Cardiovasc Pharmacol 2020 Nov 17. doi: 10.1097/FJC.0000000000000931.
PMID: 33235030